Oh ye of little faith - having just nailed down a nice little earner with a bright future why wouldn't he do his utmost to make the deal work. For HT's benefit All IMO and DYOR
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%